AFC Hikari and ADHD in kids: what the peptide claims miss

What did @afc.ae.ocha actually say?

Honestly, not much that's coherent. The transcript is almost entirely noise: "you how to survive and have become more mindsets" repeated five times with minor variation, followed by "Welcome to the new innovative economy." There is no actual product explanation, no dosing rationale, no mechanism of action described, and no clinical claim made verbally in the footage we can evaluate. The caption does the heavy lifting here, describing AFC Hikari as a "superfood vegan" supplement containing "Triple Peptide" from marigold, spearmint, and mango leaf, and claiming it "supports brain health, eye health, and nerve function" including for children with ADHD and special needs.

So we are fact-checking a caption and a product description, not a substantive verbal argument. That distinction matters, because the hashtags "autism, adhd, spechdelay" are doing significant marketing work that the creator's actual words never justify.

Does the science back this up?

For the specific ingredient combination marketed here, the honest answer is: barely, and not in children with ADHD. Let's break down each component.

Spearmint extract has the most credible small-scale evidence. A randomized controlled trial by Herrlinger et al. (2018, Nutrients) found that a proprietary spearmint extract improved working memory and spatial memory in older adults over 90 days. That is adults, not children, and not an ADHD population. The effect sizes were modest.

Marigold extract, typically standardized for lutein and zeaxanthin, has reasonable evidence for macular health (Nolan et al., 2017, British Journal of Ophthalmology) and some preliminary data on neural processing speed, again in adults. Calling this a "peptide" is a stretch. Lutein is a carotenoid, not a peptide.

Mango leaf extract standardized for mangiferin has shown anti-inflammatory and neuroprotective properties in rodent models (Saha et al., 2016, Phytomedicine), but human clinical trials in children with neurodevelopmental conditions do not exist in the peer-reviewed literature.

No published RCT examines this specific triple-ingredient combination in children with ADHD, autism, or speech delay. The leap from adult memory studies to pediatric neurodevelopmental conditions is not supported by current evidence.

What did they get wrong (or right)?

They got the marketing wrong in ways that matter. Labeling marigold and mango leaf extracts as "peptides" is inaccurate. Peptides are short chains of amino acids. Lutein from marigold is a carotenoid. Mangiferin from mango leaf is a xanthonoid. These are chemically distinct categories, and calling them peptides appears to be branding language borrowed from the legitimacy of peptide therapy research, not an accurate scientific description.

The hashtag targeting of autism, ADHD, and speech delay communities to sell a supplement with no pediatric clinical trial data is the most serious problem here. Parents of children with these diagnoses are a vulnerable audience. Implying, even through hashtag association, that a supplement addresses these conditions without evidence crosses a line from marketing into potential harm.

What they got right: spearmint extract and lutein do have genuine, if limited, cognitive and visual health evidence in adult populations. The ingredients are not dangerous. The product is vegan. None of that justifies the implied claims for children with neurodevelopmental conditions.

What should you actually know?

If your child has ADHD, autism, or a speech delay, the evidence base for nutritional supplements is genuinely limited, and the gap between "studied in adults" and "appropriate for children with this diagnosis" is enormous. The American Academy of Pediatrics does not recommend proprietary supplement blends as treatments for ADHD or autism spectrum disorder.

The most robustly studied nutritional interventions for ADHD in children involve omega-3 fatty acids, specifically EPA and DHA. A meta-analysis by Hawkey and Nigg (2014, Neuroscience and Biobehavioral Reviews) found modest but consistent effects. Even those effects are described as supplementary to, not replacements for, evidence-based behavioral and pharmacological treatment.

Before purchasing any supplement marketed toward children with neurodevelopmental conditions, ask your pediatrician or a registered dietitian whether there is peer-reviewed clinical trial data specifically in the population your child belongs to. "Supports brain health" is not a clinical outcome. It is a structure-function claim that the FDA does not require companies to prove before selling.